Diabetes has been established as an independent risk factor for lung cancer [3].Increasing evidence has shown that conventional glucose-lowering drugs such as insulin, insulin sensitisers and secretagogues, may influence the risk of cancer. This evidence concerns the gene INS and diabetes mellitus.